"This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...